验证了弗拉的营养学和神经保护药学动力学
Jeyaram Bharathi Jeyabalan1, Suhrud Pathak2, Esakkimuthukumar Mariappan3
1Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Nilgiris, Ooty, Tamil Nadu, 643001, India.
Neurochemistry international
|August 15, 2024
概括
来自饮食中的天然化合物黄,通过向多个途径,显示出保护大脑细胞免受神经退行性疾病的前景. 需要进一步的研究来确定它们的全部治疗潜力,以改善患者的治疗结果.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 营养保健品 营养保健品
背景情况:
- 神经退行性疾病涉及渐进的神经元损失和认知能力下降.
- 目前的治疗方法可以控制症状,但不能阻止疾病的进展.
- 迫切需要针对多个途径的新型治疗策略.
研究的目的:
- 探索黄作为神经保护的营养药物的治疗潜力.
- 专注于黄调节神经退行性疾病中的关键途径的能力.
- 鼓励进一步研究弗拉来缓解神经退行.
主要方法:
- 对弗拉的药理性质的新兴证据的审查.
- 对弗拉的抗氧化,抗炎和神经营养活性进行分析.
- 检查弗拉与神经保护细胞点的相互作用.
主要成果:
- 黄具有有益于神经保护的多方面的药理特性.
- 它们可以调节关键的病理生理过程,如氧化应激和神经炎症.
- 有证据表明,黄与细胞点相互作用,提供神经保护.
结论:
- 黄是神经保护的有希望的营养药候选者.
- 它们在缓解神经退行症方面的潜力需要进一步研究.
- 确定弗拉的药理动力学对于治疗应用至关重要.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Neurochemical Transmission: Sites of Drug Action
2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
111
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
111
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K


